Literature DB >> 21918792

Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.

Helen Priscila Rodrigues Martins1, Mariana Clivati da Silva, Luciene Cássia Farias Paiva, Terezinha Inez Estivalet Svidzinski, Marcia Edilaine Lopes Consolaro.   

Abstract

The aim of this study was to determine and compare the efficacy of treatment with fluconazole and nystatin in Brazilian women with vaginal Candida. In a population of 932 women, vaginal cultures were performed for yeasts, whether or not the women showed signs and symptoms of vulvovaginal candidiasis. Yeasts were isolated from 12.2% of the women (114/932): 53.2% of the yeasts were Candida albicans, 27.0% C. glabrata, 13.5% C. tropicalis and 6.3% C. parapsilosis. Treatment was carried out with both drugs. The overall mean cure rates with fluconazole (87.0%) and nystatin (74.0%) were similar; among women with non-albicans, the cure rate with fluconazole was 100%, whereas that with nystatin was 44.4%. The cure rate for women with C. albicans was high with both fluconazole and nystatin; however, for those with non-albicans species the cure rate was excellent with fluconazole and very low with nystatin, differing from the majority of in vitro studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21918792     DOI: 10.2340/00015555-1194

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis.

Authors:  Farzaneh Ebrahimy; Mahrokh Dolatian; Fariborz Moatar; Hamid Alavi Majd
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

Review 2.  Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Authors:  J D Sobel; S Suprapaneni
Journal:  Curr Infect Dis Rep       Date:  2018-08-27       Impact factor: 3.725

3.  Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.

Authors:  Armando Herrera-Arellano; Edgar O López-Villegas; Aida V Rodríguez-Tovar; Alejandro Zamilpa; Enrique Jiménez-Ferrer; Jaime Tortoriello; M Angeles Martínez-Rivera
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

4.  Ultrasound-Assisted Preparation of Exopolysaccharide/Nystatin Nanoemulsion for Treatment of Vulvovaginal Candidiasis.

Authors:  Ruiteng Song; Fang Yan; Min Cheng; Fakun Dong; Yongqi Lin; Yuzhen Wang; Bo Song
Journal:  Int J Nanomedicine       Date:  2020-03-25

5.  Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected women.

Authors:  Silvia de Souza Dantas Alczuk; Patrícia de Souza Bonfim-Mendonça; Sheila Cristina Rocha-Brischiliari; Cristiane Suemi Shinobu-Mesquita; Helen Priscilla Rodrigues Martins; Fabrícia Gimenes; André Luelsdorf Pimenta de Abreu; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso; Terezinha Inez Estivalet Svidzinski; Marcia Edilaine Lopes Consolaro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

Review 6.  Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development.

Authors:  Małgorzata Bondaryk; Wiesław Kurzątkowski; Monika Staniszewska
Journal:  Postepy Dermatol Alergol       Date:  2013-10-30       Impact factor: 1.837

7.  Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays.

Authors:  Satish T Pote; Mahesh S Sonawane; Praveen Rahi; Sunil R Shah; Yogesh S Shouche; Milind S Patole; Madhuri R Thakar; Rohit Sharma
Journal:  Infect Drug Resist       Date:  2020-04-20       Impact factor: 4.003

8.  Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis.

Authors:  Arif Khan; Mohd Azam; Masood Alam Khan; Khaled S Allemailem; Faris Alrumaihi; Ahmad Almatroudi; Fahad A Alhumaydhi; Hafiz Iqtidar Ahmad; Masih Uzzaman Khan
Journal:  Infect Drug Resist       Date:  2021-04-21       Impact factor: 4.003

9.  Prevalence of cervical-vaginal infections in the pap-smear samples in Iran.

Authors:  Cheraghi Maria; Rahimi Zahra; Parsa Sara
Journal:  Glob J Health Sci       Date:  2013-12-19

10.  Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates.

Authors:  Tchana Martinez Brandolt; Gabriel Baracy Klafke; Carla Vitola Gonçalves; Laura Riffel Bitencourt; Ana Maria Barral de Martinez; Josiara Furtado Mendes; Mário Carlos Araújo Meireles; Melissa Orzechowski Xavier
Journal:  Braz J Microbiol       Date:  2016-10-04       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.